Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 24Breast Neoplasms 8Neoplasms 3Sleep Wake Disorders 1Salivary Gland Neoplasms 1Osteoporosis 1Neoplasm Metastasis 1Fatigue 1

Interventions

Gemcitabine 57Paclitaxel 50Cyclophosphamide 45pembrolizumab 44Carboplatin 41Bevacizumab 38Cisplatin 33Docetaxel 31Fluorouracil 30Nivolumab 29Capecitabine 29Pemetrexed 24Irinotecan 24Oxaliplatin 23Dexamethasone 23Ipilimumab 22Leucovorin 21Radiotherapy 20Sorafenib 19Doxorubicin 19Everolimus 18Cetuximab 18fludarabine 17Albumin-Bound Paclitaxel 17trametinib 15Sunitinib 15Rituximab 15Erlotinib Hydrochloride 15130-nm albumin-bound paclitaxel 15Prednisone 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Neoplasms × Gonadotropin-Releasing Hormone × Clear all
NCT00587431 2023-11-07

Docetaxel With Rapid Hormonal Cycling as a Treatment for Patients With Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
102 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

NCT00586898 2016-03-25

Rapid Hormonal Cycling as Treatment for Patients With Prostate Cancer: The Men's Cycle

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
36 enrolled 6 charts
Tumor-Agnostic

Neoplasms

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Proton Collaborative Group

Phase 2/3 Terminated
2 enrolled 8 charts
Genitourinary

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡